Mitchell C. Posner to Clinical Trials as Topic
This is a "connection" page, showing publications Mitchell C. Posner has written about Clinical Trials as Topic.
Connection Strength
0.463
-
Is it ethically appropriate to continue surgical clinical trials during the COVID-19 pandemic? Surgery. 2020 07; 168(1):1-3.
Score: 0.126
-
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.
Score: 0.121
-
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013 Aug; 20(8):2787-95.
Score: 0.077
-
Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. Surgery. 2006 Apr; 139(4):455-9.
Score: 0.048
-
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review). Int J Oncol. 2004 Mar; 24(3):731-6.
Score: 0.041
-
Indications for breast-preserving surgery and adjuvant therapy in early breast cancer. Int Surg. 1994 Jan-Mar; 79(1):43-7.
Score: 0.020
-
Non-invasive breast carcinoma. Breast Cancer Res Treat. 1992; 21(3):155-64.
Score: 0.018
-
Ionizing radiation: a genetic switch for cancer therapy. Cancer Gene Ther. 2006 Jan 01; 13(1):1-6.
Score: 0.012